Neoleukin Therapeutics, Inc.
NASDAQ:NLTX
3.49 (USD) • At close December 18, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -57.557 | -60.692 | -33.277 | -69.442 | -31.585 | -50.183 | -37.002 | -21.86 | -24.027 | -8.729 | -7.714 |
| Depreciation & Amortization
| 2.612 | 2.277 | 1.821 | 0.34 | 0 | 0 | 0 | 0 | 0.136 | 0.06 | 0.131 |
| Deferred Income Tax
| 0 | 0 | 0 | 0.263 | 0 | 0 | 0 | 0 | 1.128 | -0.71 | 0 |
| Stock Based Compensation
| 8.829 | 11.557 | 5.622 | 7.683 | 4.698 | 3.839 | 1.966 | 1.506 | 1.041 | 0.349 | 0.351 |
| Change In Working Capital
| 0.885 | -0.7 | 0.966 | -1.954 | -5.431 | 0.917 | 4.706 | -0.546 | 3.597 | 1.078 | -0.046 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.034 | -0.038 | 0.001 | 0.191 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.45 | -3.614 | 0 | 0 |
| Accounts Payables
| 2.256 | -0.142 | 3.018 | -2.244 | -6.472 | 1.822 | 4.815 | -0.45 | 3.614 | 0 | 0 |
| Other Working Capital
| -1.371 | -0.558 | -2.052 | 0.29 | 1.041 | -0.905 | -0.109 | -0.58 | 3.635 | 1.077 | -0.236 |
| Other Non Cash Items
| -0.376 | 0 | 0.293 | 47.716 | 0.741 | 0.709 | 0.104 | 0.632 | 0.32 | 0.014 | 0.045 |
| Operating Cash Flow
| -45.607 | -47.558 | -24.575 | -15.394 | -31.577 | -44.718 | -30.226 | -20.268 | -17.806 | -7.938 | -7.232 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -1.11 | -3.263 | -2.219 | -0.879 | -0.049 | -0.494 | -0.713 | -0.027 | -0.114 | -0.012 | -0.006 |
| Acquisitions Net
| 0 | 0 | 0 | 0.191 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -107.524 | 0 | 0 | 0 | 0 | -5.995 | -106.442 | -60.703 | -36.475 | -2.821 | 0 |
| Sales Maturities Of Investments
| 49.5 | 0 | 0 | 0 | 56 | 70.5 | 59.097 | 13.196 | 12.99 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0.026 | 0.192 | 0 |
| Investing Cash Flow
| -59.134 | -3.263 | -2.219 | -0.688 | 55.951 | 64.011 | -48.058 | -47.533 | -23.573 | -2.641 | -0.006 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -0.055 | -0.051 | -0.049 | -0.009 | -0.032 | -0.015 | -0.004 | 0 | -2.5 | 0 | 0 |
| Common Stock Issued
| 0.134 | 0 | 71.675 | 86.216 | 0 | 0 | 75.368 | 98.038 | 53.13 | 0 | 0 |
| Common Stock Repurchased
| 0.082 | 0.372 | 0.199 | 0.56 | 0 | 0 | 0 | 0 | -0.001 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.134 | 0.411 | 5.509 | -3.97 | 0.602 | 0.438 | -4.252 | -5.09 | -5.35 | 19.584 | 0 |
| Financing Cash Flow
| 0.161 | 0.732 | 77.135 | 82.237 | 0.57 | 0.423 | 71.112 | 92.948 | 45.279 | 19.584 | 0 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0.01 | -0.048 | 0.015 | -0.053 | -0.527 | 0 | 0 | 0 |
| Net Change In Cash
| -104.58 | -50.089 | 50.341 | 66.165 | 24.896 | 19.731 | -7.225 | 24.62 | 3.9 | 9.006 | -7.239 |
| Cash At End Of Period
| 38.765 | 143.345 | 193.434 | 143.093 | 76.928 | 52.032 | 32.301 | 39.526 | 14.906 | 11.006 | 2.001 |